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Abstract
Background: Hemorrhagic transformation (HT) of ischemic stroke is a complex and heterogeneous phenomenon, which involves numerous parameters 
whose knowledge remains partial.  Large HT is often associated with poorer outcome and higher mortality, especially parenchymal hematoma type 2, 
that’s why the search of strong HT predictors is very important and can improve management of ischemic stroke patients. Our aim was to review the 
literature regarding computed tomography (CT) imaging predictors of HT and possible input of different computed tomography modalities in diagnosis 
and evaluation of HT following acute ischemic stroke. The contribution of non-contrast computed tomography, computed tomography angiography 
(CTA) and dynamic Perfusion CT (PCT) investigation in the prediction of the hemorrhagic transformation risk were studied. Multiple multicentre studies 
revealed useful information on different CT patterns predictors of symptomatic intracerebral hemorrhage after stroke, which is the most important type 
of hemorrhagic transformation from a clinician’s point of view.
Conclusions: Data from the multiple studies and trials revealed that different CT modalities show high potency in HT prediction and evaluation. 
Non-contrast CT standard investigation showed high accuracy in HT prediction by assessment of early ischemic signs, quantification of the Alberta 
Stroke Program Early CT Score (ASPECTS), grading of leukoaraiosis severity. CTA is useful in HT prediction by the assessment of collateral vessels; 
intra-arterial occlusion and ASPECTS score calculated from the CTA source images. PCT showed the best predictive values by the measurement of 
blood-brain barrier permeability.
Key words: acute ischemic stroke, hemorrhagic transformation, non-contrast computed tomography, computed tomography angiography, perfusion 
computed tomography.
Curierul medical, August 2015, Vol. 58, No 4
63
REvIEw ARTIClES
Introduction
Stroke is the third leading cause of death in industrial-
ized countries and the most frequent cause of permanent 
disability in adults worldwide [1, 2].  One of the most un-
desirable complications of ischemic stroke is hemorrhagic 
transformation (HT), which may further complicate al-
ready devastating clinical condition. HT after acute ischemic 
stroke is known to associate with poor outcome and delays 
the initiation of proper anticoagulation treatment for stroke 
with cardioembolism [3].  Historically, hemorrhagic trans-
formation, initially designated as “red softening,” has long 
been recognized by neuropathologists to occur as a natural 
consequence of ischemic brain injury.  To search for new 
treatments as well as intervention measures for HT, it is im-
portant to understand its underlying mechanism and iden-
tify its predictors [4]. 
Epidemiology.  The true incidence of hemorrhagic 
transformation remains uncertain, and reported frequencies 
vary depending on the methodology used and the underly-
ing pathogenesis of the ischemic insult [5].  Autopsy series 
have reported secondary bleeding from 51% to 71% of recent 
embolic infarctions as compared to a 2% to 21% incidence 
in non-embolic strokes [6, 7].  Computed tomography (CT) 
studies have reported hemorrhagic infarction from 26% to 
43% of non-anticoagulated patients with predominantly em-
bolic infarcts [8, 9].  With the recent large use of new dif-
ferent treatment modalities of acute ischemic stroke (AIS), 
HT rates were in detail evaluated in multiple clinical trials of 
therapeutic (intravenous and intra-arterial fibrinolysis) and 
surgical (mechanical thrombectomy and arterial stenting) 
AIS interventions. 
Basic rates reported in those trials for asymptomatic 
hemorrhagic transformation (AHT) and symptomatic hem-
orrhagic transformation (SHT) constitute: National Institute 
of Neurological Disorders and Stroke (NINDS) – 4.5% (14 
patients/ from 312 cohort size) AHT and 6.4% (20/312) 
SHT [10]; European Co-operative Acute Stroke Study-
II (ECASS-II) – 39.6% (161/407) AHT and 8.8% (36/407) 
SHT [11]; European Co-operative Acute Stroke Study-III 
(ECASS-III) – 27% (113/418) AHT and 2.4% (10/418) SHT 
[12]; Alteplase thrombolysis for acute noninterventional 
therapy in ischemic stroke (ATLANTIS) – 11.4% (31/272) 
AHT and 7.0% (19/272) SHT [13]; Safe Implementation of 
Thrombolysis in Stroke-Monitoring Study (SITS-MOST) 
– 9.6% (617/6438) AHT and 7.3% (468/6483) SHT [14]; 
Prolyse in Acute Cerebral Thromboembolism II (PROACT-
II) – 68% (73/108) AHT and 10% (11/108) SHT [15]; the 
Interventional Management of Stroke I (IMS I) – 43% 
(34/80) AHT and 6.3% (5/80) SHT [16]; the Interventional 
Management of Stroke III (IMS III) – 27.4% (119/434) AHT 
and 6.2% (27/434) SHT [17]; Safety and efficacy of me-
chanical embolectomy in acute ischemic stroke (MERCI 
Trial) – 27.7% (39/141) AHT and 7.8% (11/141) SHT [18]; 
The Penumbra Pivotal Stroke Trial (Penumbra System 
for Clot Removal in Intracranial Large Vessel Occlusive 
Disease)-16.8% (21/125) AHT and 11.2% (14/125) SHT [19]; 
Solitaire flow restoration device versus the Merci Retriever 
in patients with acute ischemic stroke (SWIFT Trial) -15.5% 
(9/58) AHT and 2.0% (1/58) SHT [20]; Trevo versus Merci 
retrievers for thrombectomy revascularization of large ves-
sel occlusions in acute ischemic stroke (TREVO-2) – 40.9% 
(36/88) AHT and 4.5% (4/88) SHT [21].
CT classification.  There is a broad spectrum of sever-
ity of hemorrhagic transformation, ranging from subtle pe-
techial hemorrhage within infarcted tissue to large-volume 
hematoma extending beyond the borders of the infarction 
[22].  All types of HT are classified regarding their Computed 
Tomography (CT) patterns in 2 large groups: hemorrhagic 
infarction (HI) and parenchymal hematoma (PH) and in-
clude two subtypes of HI (HI1 and HI2) and two subtypes of 
PH (PH1 and PH2) (Table 1) [23].  The term hemorrhagic in-
farction describes heterogeneous hyperdensity occupying a 
portion of an ischemic infarct zone on CT-imaging, whereas 
parenchymatous hematoma refers to a more homogeneous, 
dense hematoma with mass effect [24]. 
Table 1
Radiographic classification of the spectrum of 
hemorrhagic transformation, based on criteria  
proposed by Fiorelli et al. (1999)[23]
Figure 1 represents examples of four patients hospitalized 
at the Institute of Neurology and Neurosurgery (Chisinau, 
Moldova), between 01.2015-03.2015, diagnosed with acute 
ischemic stroke in the right middle cerebral artery vascular 
territory.  During hospital treatment was registered hemor-
rhagic transformation, proved by the presence of character-
istic Computed Tomography pattern – hyperdense inclu-
sions of different size and intensity, supporting various types 
of HT from HI1 to the extensive PH2.
Risk factors and predictors of HT. Several factors are as-
sociated with or predict HT. Although the usefulness of some 
of these markers in clinical practice might be limited, the 
development of imaging techniques and the identification of 
predictive biomarkers might help in the selection of patients 
at increased risk of HT [25].  Reliable clinical and radiologic 
predictors are needed to identify patients at highest risk for 
hemorrhagic transformation in order to guide the safe use of 
anticoagulants or thrombolytic therapy [26].  Initial stroke 
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severity, older age, heart disease, high blood pressure, male 
gender, obesity, baseline hyperglycemia or history of diabe-
tes, uncontrolled hypertension at presentation, antiplatelet 
therapy prior to hospitalization were reported to have sen-
sitivity in HT prediction [27-31].  But the strongest predic-
tors are characteristic imaging patterns, which are useful in 
diagnosis, evaluation and prognosis assessment in all cases 
of ischemic stroke and especially in such complication as 
HT.  Computed tomography (CT) is recommended by the 
American Heart Association as the initial modality of choice 
for stroke investigation. 
CT imaging in HT diagnosis and prediction.  It is usu-
ally assumed that CT is the gold standard for the detection 
of ICH. The diagnostic performance of CT stroke protocols 
is improved with modification of window and level settings 
[32] interpretation of CT angiographic source images, and 
CT perfusion.  Imaging of ischemic stroke and its hemor-
rhagic transformation has 4 main priorities: 1) Imaging the 
Cerebral Parenchyma (mostly is provided by non-contrast 
CT (NCCT), but additional information is supplied by 
Angiography CT source images (CTA-SI) and Perfusion CT 
(PCT) maps), 2) Intracranial Vascular Evaluation (CTA), 
3) Assessment of cerebral perfusion parameters (basic PCT 
maps), 4) Blood-Brain Barrier Permeability evaluation (per-
meability surface (PS) PCT product). 
Non-contrast CT (NCCT). Non-enhanced, or non-
contrast, CT represents the first step of all more complicated 
CT modalities (angiography and neuroperfusion), or can be 
used alone as an urgent tool in stroke management protocol. 
NCCT is the preferred modality because of its accessibility, 
speed, and patient’s tolerance, thereby permitting the rapid 
triage of patients suspected of having experienced a stroke 
[33].  Imaging the Cerebral Parenchyma by NCCT combines 
three basic roles in assessing the status of brain tissue in the 
acute stroke patient: the exclusion of hemorrhagic stroke, the 
detection of the ischemic tissue, and the exclusion of condi-
tions that mimic acute cerebral ischemia.  The perfection of 
multidetector technology has enabled a CT scan of the head 
to be obtained with submillimeter slice thickness in a few 
seconds and with superior tissue differentiation (contrast 
resolution).  Besides pure exclusion of brain hemorrhage, 
however, early data about site and severity of brain ischemia 
and their respective pathogenesis are clinically requested. 
Early computed tomographic (CT) signs of cerebral 
infarction seen within 6 hours after onset of symptoms of 
stroke may be predictive of poor functional outcome and 
clinically significant hemorrhagic transformation of the in-
farct [34, 35, 36].  Early CT signs include: dense MCA, loss 
Fig. 1.  Non-contrast Multislice Computed Tomography. 
A – Male 51 years, 3 days after symptoms (acute left hemiplegia) onset, HI type 1 transformation (small hyperdense petechiae in the center of 
large right parietal hypodensity with edema and contralateral shift of median brain structures). B – Male 71 years, 10 days after symptoms on-
set, HI type 2 (confluent hyperdensities throughout the ischemic right parietal zone, without mass effect). C – Male 60 years, 24 hours of onset 
(acute deep left hemiplegia, sopor), PH type 1 transformation (homogeneous hyperdensity 5 mm in diameter in the projection of the external 
capsule on the medial contour of large right hemispheric infarction). D – Woman 85 years, 2 hours after symptoms onset (The Glasgow Coma 
Scale 3), Right hemorrhagic transformation – hemispheric parenchymal hematoma type 2, death in a few hours of onset.
Table 2
Definition of Early CT Signs of Ischemic Stroke [37] 
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of basal ganglia outline, loss of insular ribbon, hypodensity,  
effacement of sulci or ventricles, dense cortical sulci, loss of 
gray and white matter differentiation [38, 39, 40] (definition 
of early CT signs is shown in tab. 2).
One of the most important early CT sign is the increased 
density within the occluded vessel, which represents the 
thrombus.  When this is the MCA, it is called the hyperdense 
MCA sign [42, 43], and it is seen in one third to one half of 
all cases of angiographically proven thrombosis (Fig. 2 A). 
Hence, it is an appropriate indicator of thrombus when pres-
ent, but its absence does not exclude thrombus.
Another significant early CT sign of cerebral ischemia 
within the first few hours after symptom onset is loss of 
gray-white differentiation (fig. 2 B, C), because there is an 
increase in the relative water concentration within the isch-
emic tissues.  This sign includes loss of distinction among 
the nuclei of the basal ganglia and a blending of the densi-
ties of the cortex and underlying white matter in the insula 
and over the convexities.  The subsequent swelling of the gyri 
produces sulcal effacement, which may lead to ventricular 
compression.  The sooner these signs become evident, the 
more profound is the degree of ischemia.  However, the abil-
ity of observers to detect these signs on NCCT is quite vari-
able, depending on the size of the infarct, the time between 
symptom onset and imaging, and the methodology of the 
trial itself; the detection rate appears to be 67% in cases im-
aged within 3 hours.  The rate of detection increases to 82% 
at 6 hours [41].  To offer the reliability and utility in assess-
ing early ischemic changes on NCCT examination was de-
veloped special score system – The Alberta Stroke Program 
Early CT Score (ASPECTS) with a reproducible grading sys-
tem of acute ischemic stroke in the middle cerebral artery 
(MCA) circulation territory.  
The Alberta Stroke Program Early CT Score 
(ASPECTS). The ASPECTS is a 10-point quantitative topo-
graphic CT scan score used in patients with MCA stroke. 
Segmental assessment of MCA territory is made and 1 point 
is removed from the initial score of 10 if there is evidence 
of infarction in that region [44, 45].  A normal CT scan re-
ceives ASPECTS of 10 points.  A score of 0 indicates diffuse 
involvement throughout the MCA territory.  An ASPECTS 
score less than or equal to 7 predicts worse functional out-
come in 3 months as well as symptomatic hemorrhagic 
transformation.
Fig. 3.  Axial NCCT images showing the MCA territory regions 
as defined by ASPECTS. C – Caudate, I – Insular ribbon, IC – 
Internal Capsule, L – Lentiform nucleus, M1 – Anterior MCA 
cortex, M2 – MCA cortex lateral to the insular ribbon, M3 – 
Posterior MCA cortex, M4, M5, M6 are the anterior, lateral and 
posterior MCA territories immediately superior to M1, M2 and M3, 
rostral to basal ganglia. Subcortical structures are allotted 3 points 
(C, L, and IC).  MCA cortex is allotted 7 points (insular cortex, M1, 
M2, M3, M4, M5and M6).
Fig. 2.  Non-contrast Computed Tomography. Early CT signs of acute ischemic stroke.  
A – dense middle cerebral artery sign (arrow). B – early ischemic signs in left hemisphere, slice on the level of basal 
ganglia: loss of gray and white matter differentiation, large hypodensity,  effacement of sulci, loss of lentiform nucleus 
outline (arrows). C – early ischemic signs in right hemisphere, slice on the level of the body of the lateral ventricles: loss of 
gray and white matter differentiation, hypodensity,  effacement of sulci (arrow).
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ASPECTS is determined from evaluation of two stan-
dardized regions of the MCA territory: the basal ganglia lev-
el, where the thalamus, basal ganglia, and caudate are visible, 
and the supraganglionic level, which includes the corona 
radiata and centrum semiovale (fig. 3).  All cuts with basal 
ganglionic or supraganglionic structures visible are required 
to determine if an area is involved.  The abnormality should 
be visible on at least two consecutive cuts to ensure that it is 
truly abnormal rather than a volume averaging effect (fig. 4).
The ECASS I and ECASS II studies have shown that the 
presence of early CT signs occupying more than one-third 
of the MCA territory is accompanied by an increase in the 
hemorrhagic transformation risk (especially of PH- 2 type 
in the ECASS II study) and poor clinical outcome [11]. 
The multicenter analysis of 1205 patients routinely treated 
by intravenous tPA within 3 h shows that the symptomatic 
HT rate is multiplied by more than 4 in patients with early 
signs in >1/3 of the MCA territory [47].   In the MAST-E 
study, the presence of early signs was also a strong predictor 
of hemorrhagic transformation and symptomatic ICH [29].  
In contrast, other thrombolysis studies have shown that the 
presence of early signs was related to stroke severity but was 
not independently associated with the occurrence of side 
effects [14, 15].  The ASK (Australian Streptokinase Trial) 
study, evaluating treatment with intravenous streptokinase 
within the first 4 h of ischemic stroke, did not show a signifi-
cant association between the presence of early signs and the 
occurrence of a major PH. 
Hyperdense middle cerebral artery sign.  It has been 
shown that the presence of an arterial hyperdensity on the 
pre-therapeutic brain CT scan is an independent predic-
tive factor of any tPA related to HT [46].   It was previously 
demonstrated that this sign was frequently observed in pa-
tients developing an asymptomatic HT after thrombolysis 
by intravenous tPA within the first 3 h.  In other study, the 
presence of an arterial hyperdensity on brain CT scan is as-
sociated with MCA or internal carotid artery occlusion in 
most cases and with a specific MRI pattern consisting of a 
large pretreatment diffusion and perfusion abnormality vol-
ume [48].  The presence of a proximal arterial hyperdensity, 
as the severity of perfusion reduction suggests, is probably 
associated with a limited collateral blood supply.  The maxi-
mal haemodynamic consequence lies in the territory of the 
perforating lenticulostriate arteries and the severity of the 
ischemic injury in this territory probably induces the hem-
orrhagic transformation [14].
Leukoaraiosis (LA).  Originally noted as diffuse, non-
specific subcortical white matter lesions on CT, leukoaraiosis 
is a common finding among patients with ischemic stroke 
and has been associated with poor post-stroke outcomes as 
well as increased risk for HT [51-52].  LA represents cerebral 
white matter changes that are frequently observed on CT 
and MRI scans of elderly individuals, are seen as bilateral, 
patchy, or diffuse areas of hypodensity on CT involving the 
periventricular and centrum semiovale white matter.  These 
lesions have irregular margins and do not follow specific vas-
cular territories [53]. 
The largest visual scales used for assessment of LA on CT 
are: 1) Van Swieten et al., (score 0-4).  The severity of LA is 
graded separately for the regions anterior and posterior to 
the central sulcus added together: 0 – no lesion, 1 – partial 
involvement of the white matter, and 2 – extending up to the 
subcortical region [54]. 2) Blennow et al., (score 0-3).  The fi-
nal score is the mean value between the extension and sever-
ity scores.  Extent of LA: 0 – no decrease in the attenuation of 
white matter; 1-decreased attenuation of white matter at the 
margins at the frontal and occipital horns of the lateral ven-
tricles; 2-decreased attenuation of white matter around the 
frontal and occipital horns of the lateral ventricles with some 
extension toward the centrum semiovale; and 3-decreased 
attenuation of white matter extending around the whole 
lateral ventricles and coalescing in the centrum semiovale. 
Severity of LA: 0-none, 1-mild, 2-moderate, and 3-marked 
decrease in the attenuation of white matter [55]. 
A recent retrospective multicenter study showed, that leu-
koaraiosis is a risk factor for symptomatic HT in 449 patients 
Fig. 4.  Female, 55 years. NCCT in hyperacute phase of stroke (2 hours of symptoms onset – left hemiparesis,  
right pyramidal insufficiency, visual disorders, aphasia).  
A, B – ganglionic level. C – supraganglionic level. Early signs of stroke in right MCA, ASPECTS = 6 (M1, M4, M6, I).  
Chronic bilateral lacunar infarct in thalamus.
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treated with thrombolysis for anterior circulation stroke less 
than 6 h after symptom onset [49].  For the analysis, leukoar-
aiosis in the deep white matter was dichotomized into absent 
or mild versus moderate or severe.  The rate of symptomatic 
HT was significantly higher in patients with moderate to se-
vere leukoaraiosis of the deep white matter (n = 12 of 114; 
10.5%) than in patients without relevant leukoaraiosis (n=13 
of 335; 3.8%). In a logistic regression analysis (including age, 
NIHSS score on admission and type of thrombolytic treat-
ment), leukoaraiosis remained an independent risk factor (p 
= 0.03).  Other large study of 1,153 consecutive patients with 
imaging-confirmed ischemic stroke concluded, that pres-
ence of coexisting severe leukoaraiosis predicts poor func-
tional 90-day outcome (modified Rankin Scale) in patients 
with acute intracranial large artery occlusion in anterior 
circulation independent of other known important outcome 
predictors (70% of patients in this subgroup were either se-
verely disabled or died at 90 days) [50].  
Computed Tomography Angiography (CTA).  CTA 
provides excellent imaging of intra- and extra-cranial vascu-
lature, which is essential in diagnosis of every type of cere-
brovascular disease, especially acute ischemic stroke.  Recent 
studies show that CTA is a safe and accurate technique for 
imaging most extracranial and intracranial vessels for steno-
sis/occlusions with the sensitivity and specificity equal to or 
superior to that of MRA (Magnetic Resonance Angiography) 
in most circumstances, and in some cases, its overall accu-
racy approaches or exceeds that of DSA [56, 57].  For the 
acute stroke patient, vascular imaging plays several roles: 
1) differentiation of real occlusion from transient ischemic 
attack, or other cerebrovascular disease and establishing 
the mechanism of ischemia to prevent subsequent episodes, 
2) visualization of the localization of the site of vascular oc-
clusion, extent and morphology of thrombus, 3) assessment 
of collaterals status and 4) analysis of cerebral parenchyma 
on CTA source images (CTA-SI).
A recent retrospective multi-center study of 263 patients 
showed, that the quantification of intracranial thrombus ex-
tent predicts functional outcome, final infarct size and risk of 
HT [58].  This study group developed the clot burden score 
(CBS) -a semiquantitative CTA grading system in acute an-
terior circulation ischemic stroke to quantify the extent of 
ipsilateral intracranial thrombus, allotting major arteries 10 
points for the presence of contrast opacification on CTA. 2 
points each were subtracted for absence of contrast opacifi-
cation in the complete cross-section of any part of the proxi-
mal M1 segment, distal M1 segment or supraclinoid ICA 
and 1 point each for M2 branches, A1 segment and infra-
clinoid ICA (Fig 5, A).  A score of 10 indicates absence of 
a visible occlusion on CTA, a score of 0 indicates occlusion 
of all major intracranial anterior circulation arteries.  Study 
group found, that patients with lower CBS were more likely 
to have hemorrhagic infarct transformation (P = 0,003) and 
parenchymal hematoma (P = 0,008) on follow-up scans [58].
Collateral flow. Next extremely important CTA param-
eter is the development grade of collateralls in the infarcted 
hemisphere (fig. 5, B, C, D).  The presence of robust collater-
al flow is associated with rapid recanalization in acute isch-
emic stroke and reduction of infarct size [60].  The PROACT 
II trial investigators semiquantitatively analyzed pial collat-
eral formation on angiography and categorized them as full, 
partial, or none and found that presence of good collaterals 
influences NIHSS score at initial presentation, infarct vol-
ume and HT rate on 24-hour CT scan in patients with MCA 
occlusion.  The presence of collaterals has also been associ-
ated with better outcomes, reduced infarct size, and faster 
recanalization [15].  In the study Lin K. et al., 2012, the CTA 
collateral score was graded using a 4-point scale from 0 to 
3 (“0”–absent collateral supply; “1”– collateral supply filling 
>0 but ≤ 50%; “2”– collateral supply filling >50 but <100%; 
and “3”– collateral supply filling 100% of the occluded MCA 
territory compared to the contralateral side) and compared 
with HT rate.  Data analysis revealed significant associa-
tions between symptomatic HT and proximal occlusion 
(p = 0.049) and collateral score (p = 0.017) [59].
Computed tomography angiogram-source images 
(CTA-SI).  The source images of the brain during CTA ac-
quisition make a focus of hypoperfusion much more detect-
able than does the NCCT (Fig 6).  Lev et al., [32] demon-
strated the very high correlation between size of the infarct 
on CTA-SI and that which was demonstrated on follow-up 
CT studies.  Hypoattenuation on brain CTA source images is 
attributable to early ischemic edema and a diminished con-
Fig. 5.  Cerebral CTA.  A – visualization of thrombus in an occluded right middle cerebral artery (black arrow). 
3 grades of collaterals development: B – poor collaterals in right ischemic hemisphere, C – intermediate collaterals in 
the left MCA territory, D – good collaterals in left MCA ischemic circulation.
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trast agent–exchanging blood pool.  Results of pilot studies 
have suggested that hypoattenuation on CTA source images 
delineates ischemic tissue likely to be irreversibly infarcted 
and that lesion volume is seen on CTA source images.  Focal 
hypoattenuation on CTA source images may reflect a pro-
found degree of ischemia- induced endothelial injury with 
increased risk of reperfusion hemorrhage or inadequate lep-
tomeningeal collateral blood flow.  Data suggested that axial 
source images provide a visually detectable threshold of hy-
poattenuation without post-processing that is a powerful 
independent predictor of both HT and poor outcome [61]. 
Regions of abnormality on the NCCT usually cannot be seg-
mented prospectively because of their ill-defined borders; 
areas of abnormality are more conspicuous on CTA source 
images. ASPECTS calculated on the CTA-SI have shown 
that CTA-SI is better at depicting early ischemic change 
than NCCT and therefore offers a more accurate score [59]. 
Investigators found that threshold at ASPECTS ≤5 on CTA-
SI had high sensitivity (75.0%) and specificity (85.5%) for 
symptomatic HT [59].  Comparing CTA-SI and NCCT im-
ages Aviv et al., found that CTA-SI improved trainee accu-
racy by 9%, but had little impact on more experienced read-
ers.  The accuracy and sensitivity of stroke extent assessment 
was increased for all readers, but was greatest for the trainee 
(17% and 12%, respectively).  Clinical history contributed 
little to CTA-SI accuracy.  Observer resolution was higher 
for CTA-SI. NCCT could have resulted in the misclassifica-
tion of more patients than CTA-SI [62].
Computed Tomography Perfusion (CTP).  CT perfu-
sion imaging uses dynamic contrast- enhanced data to pro-
duce parametric color overlay maps of cerebral blood flow 
(CBF), cerebral blood volume (CBV), mean transit time 
(MTT) and time to local peak enhancement (TTP) (fig. 
7).  These standard perfusion metrics are used to detect an 
acute ischemic stroke and the presence of “penumbra,” the 
hypoperfused but potentially salvageable tissue at risk of in-
farction [63-65].  CTP, can not only provide the diagnostic 
information about ischemic region, but and the functional 
brain data about blood-brain barrier (BBB) physiology, es-
pecially its permeability.  HT is generally thought to arise 
from ischemic damage to the blood-brain barrier (BBB), 
expressed in elevated permeability.  Microvascular perme-
ability (expressed as the transendothelial transfer of constant 
or permeability surface area product [PS]) is a metric of BBB 
integrity. Increased blood–brain barrier permeability, one of 
the pathological changes following ischemic stroke, is be-
lieved to predispose to complications such as hemorrhagic 
transformation [79], massive vasogenic edema, infarct ex-
pansion [80] and poor clinical outcome [81, 78].  Like the 
standard perfusion metrics, PS can also be calculated using 
dynamic imaging by measuring the leakage of an intravascu-
lar tracer (contrast agent) into the extravascular (interstitial) 
space [66, 67].  BBB permeability imaging provides a physi-
ologic individualized measurement intimately connected to 
the underlying pathophysiology of PH-2 (ischemia-induced 
vascular damage followed by reperfusion) and may, there-
fore, offer excellent sensitivity and specificity (fig. 8).
Recent study [68] showed, that there was complete sep-
aration of PS in HT group and PS and in non-HT group 
measurements; any PS between 6.0 and 9.8 mL/100 mg per 
minute can be used as a threshold value to predict HT with a 
sensitivity and specificity of 100%.  Investigators showed that 
elevated PS can be detected during hyper-acute period using 
first-pass dynamic CT data.  Patients with high PS who were 
not treated with recombinant tissue plasminogen activator 
(rtPA) tended to develop smaller petechial hemorrhagic in-
farctions that were asymptomatic.  Christopher D. d’Esterre 
(2013) demonstrated, that the patients with HT had a sig-
nificantly higher PS than did those without haemorrhage. 
A PS threshold of 0.23 ml-1•min-1•(100g)-1
 
also enabled the 
differentiation of patients with HT from those without [69]. 
Results showed that besides the PS parameter and ASPECT 
score, no other factors (age, sex, or baseline NIHSS score) 
were associated with HT.  Hom J et al., investigated the op-
portunities of  perfusion CT in prediction of HT and ma-
lignant edema in patients with acute ischemic stroke [76]. 
They reported that using admission BBB perfusion imaging 
above a volume threshold as the sole predictor yields a sen-
Fig. 6.  Hyper-acute ischemic stroke in the left posterior cerebral artery circulation territory (arrow). 
A – NCCT, very difficult detectable early CT signs of ischemic lesion. B – CTA-SI, clearly detectable 
hypo-attenuation zone in the projection of left occipital lobe. C – follow up CT in subacute phase, 
confirming CTA-SI findings.
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Fig. 8.  Female, 57 years, acute (2 hour from the symptoms onset) ischemic stroke in left middle cerebral artery circulation territory. 
CT perfusion functional maps.  A – non-contrast CT, there is no evidence of abnormalities,  B – CBF,  C – CBV, 
D – MTT, E – permeability surface area product (PS), F – non-contrast CT 26 hours after symptoms onset, hemorrhagic  
transformation, parenchymatous hematoma type 2.
Fig. 7.  Female, 84 years, acute (1 hour from the symptoms onset) ischemic stroke in left middle cerebral artery circulation territory. 
Standard CT perfusion maps.  A – CBF.  B – CBV. C – MTT.
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sitivity of 100% and specificity of 79% (5 false-positives from 
32).  Reperfusion was a statistically significant predictor of 
SHT in the univariate analysis, but the reperfusion scores in 
patients with SHT were lower than those in other patients, 
not higher as we would have expected on the basis of the role 
of reperfusion in SHT [77]. 
Other (not PS) functional Perfusion CT parameters were 
studied to determine their correlation with HT and results 
failed to show any difference with statistical importance, 
with only exception for the relative cerebral blood volume 
(rCBV) map.  Patients with HT had higher median total vol-
ume at risk of ischemia, longer median relative mean transit 
time (rMTT), and lower median relative cerebral blood flow 
(rCBF) compared with controls, though this did not reach 
statistical significance.  Cases with HT did have a significant-
ly lower median rCBV compared with controls (p = 0.01). 
For each 0.1-U decrease in rCBV, the odds of developing 
an HT increases by 14% [70].  Prediction of HT by reduced 
pretherapeutic CBF, an inherent characteristic of the stroke 
itself, was first suggested by Ueda et al., by using SPECT [71]. 
A reduction in CBF to <50% of normal was considered as the 
critical value for developing HT [72].  Gupta et al., in their 
study of 23 patients with symptomatic stroke or carotid ste-
nosis concluded that mean ipsilateral CBF <13 mL/100 g per 
minute was the cutoff for developing HT [73].  They found 
that rCBV rather than rCBF was the strongest predictor of 
HT.  This is similar to reports of rCBV (rather than rCBF) 
being a stronger predictor of penumbra viability in patients 
with acute ischemic stroke [74], with similar [75] or even 
lower [59] values reported by authors for rCBV in patients 
with HT.  In other words, indicators of penumbra viability 
may also indirectly predict HT, which would be expected to 
occur more frequently in infarcted core rather than salvage-
able penumbra regions.  Jain et al., found that a cutoff rCBV 
of at least 0.98 could predict development of HT in patients 
with AIS with 72% specificity [70]. 
Multimodality Computed Tomography.  Different CT 
modalities showed different accuracy in prediction of hem-
orrhagic transformation, but most of studies reported better 
sensitivity and specificity for the Perfusion CT.  Darius G. 
Nabavi et al., published a novel imaging CT algorithm us-
ing all 3 CT methods and developed a new scoring system – 
MOSAIC: Multimodal Stroke Assessment Using Computed 
Tomography [82].  With 3 main CT modalities (NCCT, 
CTA, PCT), profound knowledge about brain anatomy, 
vessel status, and tissue hemodynamics can be acquired in 
acute stroke patients within several minutes.  The calcula-
tion is made by adding scores from every CT modality: 
1) Early signs of infarction on NCCT: 0 = No infarction signs, 
1 = 1–3 ASPECTS regions infarcted, 2 = >4 ASPECTS re-
gions infarcted. 2) Ipsilateral pathology on CTA: 0= Normal 
or stenosis <50%, 1= ICA/MCA stenosis >50%, 2= ICA/
MCA occlusion. 3) PCTCBF slice-1: 0 = No perfusion defi-
cit, 1= Perfusion deficit <20%, 2= Perfusion deficit > 20%. 
4) PCTCBF slice-2: 0= No perfusion deficit, 1= Perfusion 
deficit <20%, 2= Perfusion deficit >20%.  The range of pos-
sible points consists from 0 to 8, with the lowest MOSAIC 
score of 0 representing normal findings in all 3 modalities. 
Linear regression analysis between CT results and out-
come measures revealed consistent differences among the 
4 CT components for all target parameters: of the 3 single 
CT components, the ASPECTS score on NCCT showed the 
lowest correlation coefficients (r =0.42 to 0.58), whereas 
PCTCBF  consistently showed the highest values (r =0.52 
to 0.75) with respect to clinical status and infarction size. 
With respect to the correlation coefficients on linear regres-
sion analysis, MOSAIC was superior to all single CT com-
ponents (r=0.59 to 0.78): sensitivity values were the lowest 
for NCCT (58.9%), followed by CTA (66.7%) and PCTCBF 
(71.8%), whereas the MOSAIC score showed the highest 
values (87.1%); the specificity with respect to occurrence of 
infarction was 100% for all parameters.  The combination of 
3 CT modalities was superior to all single CT components 
with respect to the various outcome measures and showed 
a strong correlation to the size of infarction (r=0.78) [82]. 
Conclusions
Hemorrhagic transformation (HT), which refers to a 
spectrum of ischemia-related brain hemorrhage, is a fre-
quent spontaneous complication of ischemic stroke and still 
represents the most feared complication.  HT is a complex 
and multifactorial phenomenon and it is important to un-
derstand its underlying mechanism and identify its predic-
tors.  Different CT modalities are largely used worldwide for 
the ischemic stroke diagnosis and evaluation of their pos-
sibilities in HT prediction has been intensely studied in re-
cent years.  Non-contrast CT standard investigation showed 
high sensitivity and specificity values in assessment of early 
ischemic signs (dense MCA,  loss of basal ganglia outline, 
loss of insular ribbon, hypodensity,  effacement of sulci or 
ventricles, dense cortical sulci, loss of gray and white matter 
differentiation) in correlation with HT prediction.  The most 
useful methods in HT prediction on CT were reported to be 
low The Alberta Stroke Program Early CT score (ASPECTS), 
presence of dense MCA, leukoaraiosis and early CT signs in 
1/3 of middle cerebral artery territory.  Another application 
of NCCT in relation to HT – is timely diagnosis and clas-
sification of its various types (hemorrhagic infarction type 1 
and 2, parenchymal hematoma type 1 and 2) and dynamics 
of low-up. Next CT modality is Angiography, which showed 
the potential in HT prediction by the assessment of the col-
lateral flow grade; presence, localization and extent of intra-
arterial occlusion and ASPECTS score calculated from the 
ACT source images.  Last CT modality is dynamic func-
tional Perfusion imaging, which includes large spectrum of 
quantitative parameters (cerebral blood flow, cerebral blood 
volume, mean transit time, time to peak enhancement and 
permeability surface area product).  Microvascular perme-
ability (expressed as the transendothelial transfer of constant 
agent) expressed in color PS (permeability surface) map 
calculated from the Perfusion CT data showed the best re-
sults in HT prediction.  The combination of 3 CT modalities 
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(MOSAIC scoring system: Multimodal Stroke Assessment 
Using Computed Tomography) was superior to all single CT 
components and showed a strong correlation to the size of 
infarction, clinical outcome and HT prediction. 
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